This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Janssen Pharmaceutica Nv. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations in Cancer Treatment by Anthony T Greway
Introduction
Anthony T Greway is an accomplished inventor based in Bound Brook, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic methods.
Latest Patents
Greway holds a patent for "Methods of treating cancer using PRMT5 inhibitors." This patent outlines methods for treating human patients diagnosed with cancer by administering a therapeutically effective amount of a PRMT5 (protein arginine methyltransferase 5) inhibitor. The methods include administering initial doses of at least about 0.1 mg per day of a specific PRMT5 inhibitor for an initial dosing period of about 5 to 21 days, followed by subsequent doses for additional periods.
Career Highlights
Greway is currently associated with Janssen Pharmaceutica NV, where he continues to advance his research in cancer therapies. His work focuses on developing effective treatment protocols that can significantly improve patient outcomes.
Collaborations
Some of his notable coworkers include Hillary Joy Millar Quinn and Kathryn Elizabeth Packman, who contribute to the collaborative efforts in research and development at Janssen Pharmaceutica NV.
Conclusion
Anthony T Greway's innovative work in cancer treatment exemplifies the impact of dedicated research and collaboration in the medical field. His contributions are paving the way for more effective therapies that can benefit patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile